ArticleBiology2026
Circulating Homocysteine and Choroid Plexus Volume Across the Alzheimer's Disease Continuum: Cross-Sectional and Progression-Related Associations.
Article in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundElevated plasma homocysteine (HCY) is a risk factor for Alzheimer's disease (AD), but its relationship with structural brain changes across the AD continuum remains unclear. The choroid plexus (CP) regulates cerebrospinal fluid homeostasis and may interface with peripheral metabolic signals. Whether HCY relates to CP structural alterations and disease progression remains unknown.
methodsWe analyzed 819 Alzheimer's Disease Neuroimaging Initiative (ADNI) participants (229 cognitively normal (CN), 397 with mild cognitive impairment (MCI), and 193 with AD dementia). Multinomial logistic regression assessed associations between HCY and diagnosis under stepwise covariate adjustment. Phenotype-wide structural magnetic resonance imaging (MRI) mapping identified HCY-associated signals. Cox models evaluated associations of CP volume (CPV) with CN-to-MCI and MCI-to-AD dementia conversion and whether CPV added prognostic discrimination beyond baseline disease-severity markers. Independent human CP single-nucleus and spatial transcriptomic datasets were reanalyzed to characterize epithelial expression states and their spatial organization in a hypothesis-generating analysis.
resultsHigher HCY was associated with MCI and AD dementia; however, the AD association attenuated after adjustment for renal function, vitamin B12, and medications, whereas the MCI association remained stable. CPV was among the HCY-associated MRI signals that persisted after progressive covariate adjustment. Right and bilateral CPV showed model-dependent associations with MCI-to-AD dementia conversion. In the disease-severity sensitivity analysis, larger right and bilateral CPV remained associated with a higher risk of progression from MCI to AD dementia. Single-nucleus analysis identified two CP epithelial states with relatively high expression of one-carbon metabolism-related genes, termed one-carbon metabolism-enriched epithelial state A (OCM-Epi-A) and state B (OCM-Epi-B). Donor-level pseudobulk analysis did not identify pathway enrichment after false discovery rate correction, whereas OCM-Epi-A-like spots were located near endothelial spots more often than expected by chance in three of the four spatial samples.
conclusionsCirculating HCY was associated with larger CPV, and larger CPV showed model-dependent associations with MCI-to-AD dementia progression. Independent transcriptomic reanalysis identified one-carbon metabolism-enriched epithelial states and their spatial organization in postmortem CP tissue, providing hypothesis-generating tissue-level context for the ADNI associations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.